These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 12627516)

  • 1. Trends in prostate cancer mortality among black men and white men in the United States.
    Chu KC; Tarone RE; Freeman HP
    Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer incidence and mortality rates among white and black men.
    Merrill RM; Brawley OW
    Epidemiology; 1997 Mar; 8(2):126-31. PubMed ID: 9229202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.
    Tarone RE; Chu KC; Brawley OW
    Epidemiology; 2000 Mar; 11(2):167-70. PubMed ID: 11021614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994.
    Schwartz KL; Severson RK; Gurney JG; Montie JE
    Cancer; 1996 Sep; 78(6):1260-6. PubMed ID: 8826949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
    Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
    Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States.
    Legler JM; Feuer EJ; Potosky AL; Merrill RM; Kramer BS
    Cancer Causes Control; 1998 Oct; 9(5):519-27. PubMed ID: 9934717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
    Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
    Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001.
    Sarma AV; Schottenfeld D
    Semin Urol Oncol; 2002 Feb; 20(1):3-9. PubMed ID: 11828352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is prostate cancer stage migration continuing for black men in the PSA era?
    Dobbs RW; Greenwald DT; Wadhwa H; Freeman VL; Abern MR
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):210-215. PubMed ID: 28094251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lifetime risk of developing prostate cancer in white and black men.
    Merrill RM; Weed DL; Feuer EJ
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):763-8. PubMed ID: 9332756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.
    Etzioni R; Legler JM; Feuer EJ; Merrill RM; Cronin KA; Hankey BF
    J Natl Cancer Inst; 1999 Jun; 91(12):1033-9. PubMed ID: 10379966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
    Dall'Era MA; deVere-White R; Rodriguez D; Cress R
    Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
    Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
    Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
    Kelly SP; Anderson WF; Rosenberg PS; Cook MB
    Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015.
    Rodriguez S; Sparks AD; Zhou H; Amdu RL; Lin J
    Can J Urol; 2019 Oct; 26(5):9946-9951. PubMed ID: 31629445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.